THE PERSHING SQUARE SOHN CANCER RESEARCH ALLIANCE is accepting applications for its Prize for Young Investigators in Cancer Research.
The Fiscal Year 2016 Defense Appropriations Act provides $120 million to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative, high-impact breast cancer research to accelerate progress toward ending breast cancer.
Applications are being accepted for the ACMG Foundation/Shire Laboratory Geneticist Fellowship Awards and Clinical Genetics Residency Program. The program will facilitate 10 one-to-two-year training awards for medical geneticists over the next three years, after a $1.65 million commitment from Shire.
Stand Up To Cancer announced a request for proposals under SU2C Catalyst, a program supporting clinical trials and translational research.
The Department of Defense Lung Cancer Research Program is accepting preapplications and letters of intent for concept award grant, worth up to $100,000 for one year, for direct costs not related directly to clinical trials.
CureSearch for Children's Cancer began taking applications for its International Grand Challenge Awards addressing three challenges in pediatric cancer treatment. The awards will be worth between $2 million and $3 million.
FDA will provide $2 million in two to five research grants for the study of the natural history of rare diseases. The objective of the grants is to expedite the development of products for these conditions.
The American Association for Cancer Research and Bayer announced the 2016 AACR-Bayer Innovation and Discovery Grants program for meritorious projects that examine novel targets and biomarkers in oncology research.
DEBBIE'S DREAM FOUNDATION: Curing Stomach Cancer launched two research grants totaling $200,000 for the 2015-2016 grant cycle. A Career Development Award for $150,000 and a Young Fellowship Grant for $50,000 are being offered.
NCI is taking applications for its Research Specialist Award, which is designed to encourage the development of stable research career opportunities for scientists who want to pursue research within the context of an existing cancer research program, but not serve as independent investigators.